HansBiomed USA is a leading bio-engineering company that manufactures different types of orthobiologics such as DBM and allograft. HansBiomed has the largest bio-engineering research institute in Asia and have received 510(k) approval for DBM products. As the first tissue bank established in Korea, HansBiomed has been developing a variety of biologic products
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a top-biotech joint venture specializing in the research, development, manufacture and marketing of medical device and pharmaceuticals based on gene engineering and biochemical technology since 1993. Our core product is Bone Repair Materials, applicable for bone defect, nonunion treatment as well as oral and spinal procedures. It achieves an annual global sales volume of USD115 million, delivering reliable clinical solutions.
Fidia Pharma USA
Fidia provides innovative products for orthopedic care. Our hyaluronan-based viscosupplements include HYALGAN®, the first HA approved in the US for osteoarthritis knee pain, 3-injection TRILURON®, HYMOVIS®, the only 2-injection non-crosslinked hydrogel, and now HYMOVIS® ONE the only non-avian, non-crosslinked, bacterially fermented single injection. RichPlat Ortho™ Platelet Rich Plasma System delivers high-quality PRP with a closed-system kit. Visit fidiapharma.us to learn more.
EVERGEN
We are a world-class Contract Development and Manufacturing Organization (CDMO) driven by a patient-first approach to innovation. Starting from the patient need, we partner with Original Equipment Manufacturers (OEMs) to develop and deliver customized regenerative biomaterial solutions with a goal to promote healing, accelerate recovery, and help prevent complications to enhance patient lives. | Evergen is a leading Contract Development and Manufacturing Organization (CDMO) pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. Using our extensive portfolio of biological materials, we focus on specialized clinical segments, including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neurosurgery. | Evergen is a leading Contract Development and Manufacturing Organization (CDMO) pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. Using our extensive portfolio of biological materials, we focus on specialized clinical segments, including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neurosurgery. Headquartered in Alachua, Florida, Evergen has facilities in the United States, Europe and New Zealand. For more information, visit www.evergenbio.com. | We are a world-class Contract Development and Manufacturing Organization (CDMO) driven by a patient-first approach to innovation. Starting from the patient’s needs, we partner with Original Equipment Manufacturers (OEMs) to develop and deliver customized regenerative biomaterial solutions with a goal to promote healing, accelerate recovery, and help prevent complications to enhance patient lives.
Emergent CRO
Emergent CRO is a MedTech-focused clinical research organization supporting orthopedic, spine, and sports medicine innovators from first-in-human through post-market. We deliver senior-level oversight, agile execution, and transparent pricing. Acting as an extension of your team, we integrate seamlessly to design smarter studies, activate the right sites, and keep trials moving forward. We don’t just manage studies, we become true partners in your success. Built to Care. Built for MedTech!
CaP Biomaterials, llc
CaP Biomaterials manufactures high-quality, custom fabricated calcium phosphate products in the US for biomedical applications worldwide. CaP calcium phosphates are used for HA coatings, bone void fillers (cements, injectables and putty products) and for additive manufacturing. CaP is ISO 13485:2016 certified and provides cost-effective calcium phosphate biomaterials to customer specifications. Our in-house analytical capabilities include dissolution and solubility testing.
BONESUPPORT AB
BONESUPPORT is advancing bone infection management for Arthroplasty, Trauma, and Foot & Ankle surgeons. We are an orthobiologics company and the maker CERAMENT® G with Gentamicin, the only FDA authorized bone remodeling technology that is injectable and elutes antibiotics. Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
BONEGRAFT BİYOLOJİK MALZEMELER SAN. VE TİC. A.Ş.
BONEGRAFT BIOLOGICAL MATERIALS INDUSTRY AND TRADE INC. ABOUT THE COMPANY Bonegraft is a company focused on the design, development, manufacturing, and marketing of synthetic bone and cartilage graft products in the healthcare biotechnology sector. In January 2017, Bonegraft’s R&D laboratory was established at the Ege University Technology Development Center under ISO-7 (Class 10,000) cleanroom conditions. Bonegraft’s primary goal is to become a leading player in the national and international
BMT Baps
BMT Baps is developer and manufacturer of next generation implants, made from 100% synthetic & biocomposite material, for cartilage regeneration, arthroscopy, sports surgery and orthopedics.